Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P246: The association of serum 7α-hydroxy-4-cholesten-3-one (7C4) with Bile Acid Diarrhoea in patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

R. Battat1,2*, M. Duijvestein2, N. Vande Casteele2,3, S. Singh1, M. Renshaw4, J. McFarland4, H. Chen4, A. Jain4, W.J. Sandborn3, B.S. Boland3

1University of California, San Diego, Division of Gastroenterology, La Jolla, USA, 2Robarts Clinical Trials, La Jolla, USA, 3University of California, Division of Gastroenterology, La Jolla, USA, 4Prometheus Laboratories Inc., La Jolla, USA

P247: MR enterography in Crohn’s disease: Comparison between diffusion-weighted imaging and intravenous contrast material in detection of active diseaseECCO '18 Vienna
Year: 2018
Authors:

A. Geccherle1, A. Variola1*, A. Massella1, E. Demozzi2, E. Oliboni2, G. Carbognin2, L. Romano2

1Ospedale Sacro Cuore Don Calabria, IBD Unit, Negrar, Italy, 2Ospedale Sacro Cuore Don Calabria, Radiology, Negrar, Italy

P248: IL-33/ST2 levels can predict mucosal response to anti-TNF therapy in ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

L.R. Lopetuso1,2*, V. Petito1, C. Graziani1, T.T. Pizarro2, A. Armuzzi1, A. Gasbarrini1, F. Scaldaferri1

1Catholic University of Sacred Heart, Internal Medicine Department, Gastroenterology Division, Rome, Italy, 2Case Western Reserve University, Pathology, Cleveland, USA

P249: Endoscopic score vs. faecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healingECCO '18 Vienna
Year: 2018
Authors:

T. Yamamoto*, T. Shimoyama, S. Umegae

Yokkaichi Hazu Medical Centre, Inflammatory Bowel Disease Centre, Yokkaichi, Japan

P250: Serious infection in patients with Crohn’s disease newly treated with anti-integrin and anti-tumour necrosis factor agents: A real-world studyECCO '18 Vienna
Year: 2018
Authors:

A. Afzali1*, X. Song2, N. Shi2, M. Skup3, W.-J. Lee3

1The Ohio State University – Wexner Medical Center, Columbus, USA, 2Truven Health Analytics, an IBM Company, Cambridge, USA, 3AbbVie Inc., North Chicago, USA

P251: High anti-TNF drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel diseasesECCO '18 Vienna
Year: 2018
Authors:

G. Bodini1*, M.G. Demarzo1, M. Saracco1, C. Coppo1, I. Baldissarro1, J. Anjali2, E. Savarino3, V. Savarino1, E. Giannini1

1Policlinico San Martino, University of Genoa, Department of Internal Medicine, Genoa, Italy, 2Prometheus Laboratories, Department of Research and Development, San Diego, California, USA, 3University of Padua, Department of Surgery, Oncology and Gastroenterology, Padova, Italy

P252: Assessment of ulcerative colitis using histological indexesECCO '18 Vienna
Year: 2018
Authors:

F. Magro1,2,3, J. Lopes4, P. Borralho5, S. Lopes6, R. Coelho6, J. Cotter7, F. Dias de Castro7, H. T. Sousa8, P. Lago9, M. Salgado9, P. Andrade6, A.I. Vieira10, P. Figueiredo10, P. Caldeira11, A. Sousa11, M.A. Duarte12, F. Ávila12, J. Silva13, J. Moleiro13, S. Mendes14, S. Giestas14, P. Ministro15, P. Sousa15, R. Gonçalves16, B. Gonçalves16, A. Oliveira17, I. Rosa18, M. Rodrigues4, C. Chagas19, J. Torres20, C.C. Dias21,22, J. Afonso1,3*, K. Geboes23, F. Carneiro4,24

1Faculty of Medicine, University of Porto,, Department of Biomedicine, Unit of Pharmacology and Therapeutics, Porto, Portugal, 2Centro Hospitalar São João, Gastroenterology Department, Porto, Portugal, 3Centre for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal, 4Faculty of Medicine, Centro Hospitalar Sao Joao, Department of Pathology, Porto, Portugal, 5Faculty of Medicine, University of Lisbon, Institute of Pathology, Lisbon, Portugal, 6Centro Hospitalar São Joao, Department of Gastroenterology, Porto, Portugal, 7Hospital da Senhora da Oliveira, Department of Gastroenterology, Guimarães, Portugal, 8Centro Hospitalar do Algarve, Gastroenterology Department, Portimão, Portugal, 9Centro Hospitalar do Porto, Department of Gastroenterology, Porto, Portugal, 10Hospital Garcia de Orta, Department of Gastroenterology, Almada, Portugal, 11Centro Hospitalar do Algarve, Department of Gastroenterology, Faro, Portugal, 12Divino Espírito Santo Hospital, Department of Gastroenterology, Ponta Delgada, Portugal, 13Instituto Português do Oncologia de Lisboa, Department of Gastroenterology, Lisboa, Portugal, 14Centro hospitalar e Universitário de Coimbra, Department of Gastroenterology, Coimbra, Portugal, 15Centro Hospitalar Tondela-Viseu, Department of Gastroenterology, Viseu, Portugal, 16Hospital de Braga, Department of Gastroenterology, Braga, Portugal, 17Hospital Fernando da Fonseca, Department of Gastroenterology, Amadora, Portugal, 18Instituto Português de Oncologia de Lisboa,, Gastroenterology Department, Lisboa, Portugal, 19Centro Hospitalar Lisboa Ocidental, Department of Gastroenterology, Lisbon, Portugal, 20Hospital Beatriz Angelo, Department of Gastroenterology, Loures, Portugal, 21Faculty of Medicine, University of Porto, Health Information and Decision Sciences Department, Porto, Portugal, 22Center for Health Technology and Services Research, Porto, Portugal, 23University Hospital of KU Leuven and UZ Gent, Department of Pathology, Leuven, Belgium, 24Instituto de Investigação e Inovação na Saúde (I3S), Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal

P253: Characteristics of patients with Crohn’s disease diagnosed in the emergency department: Experience in a single tertiary hospitalECCO '18 Vienna
Year: 2018
Authors:

S.W. Lee1*, S.K. Kim1, E.S. Kim1, H.S. Lee2, Y.H. Kwon2, S.Y. Nam2, N. You1, J.S. Lee1, S. Jin1

1Kyungpook National University Hospital, Kyungpook National University School of Medicine, Division of Gastroenterology, Department of Internal Medicine, Daegu, South Korea, 2Kyungpook National University Medical Center, Kyungpook National University School of Medicine, Division of Gastroenterology, Department of Internal Medicine, Daegu, South Korea

P254: The significance of LCI Index of rectal mucosa of the patients of ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

K. Uchiyama1*, T. Takagi1, S. Kashiwagi1, Y. Toyokawa1, N. Yagi2, Y. Naito1, Y. Itoh1

1Kyoto Prefectural University of Medicine, Molecular Gastroenterology and Hepatology, Kyoto, Japan, 2Murakami Memorial Hospital, Asahi University, Department of Gastroenterology, Gifu, Japan

P255: Limitations of a community calprotectin service and outcomes from patients tested outside of an approved pathwayECCO '18 Vienna
Year: 2018
Authors:

L. James1, R. Gama1, C. Ford1, B. McKaig2, S. Whitehead1, S. Pelitari2, H. Steed2, M. Brookes2*

1The Royal Wolverhampton NHS Trust, Department of Clinical Chemistry, Wolverhampton, UK, 2The Royal Wolverhampton NHS Trust, Department of Gastroenterology, Wolverhampton, UK

P256: Risk of relapse according to endoscopic score of mucosal healing (mayo score 0 vs. 1): Clinical evaluation is still necessaryECCO '18 Vienna
Year: 2018
Authors:

L. Ramos1*, R. De La Barreda1, M. Carrillo-Palau1, I. Alonso-Abreu1, N. Hernández-Álvarez1, G. Hernández1, A. Hernandez Camba1, L. Martínez-Blanco2, A. Jiménez3, E. Quintero Carrión1,4

1Hospital Universitario de Canarias, Gastroenterology, La Laguna, Spain, 2Hospital Universitario de Canarias, Pathology, La Laguna, Spain, 3Hospital Universitario de Canarias, Research Unit, La Laguna, Spain, 4Universidad de La Laguna, La Laguna, Spain

P257: Surgical and hospital admission in adults newly diagnosed with inflammatory bowel disease (IBD) in the biological era in Spain: Results of the nationwide EpidemIBD study of GETECCUECCO '18 Vienna
Year: 2018
Authors:

M. Chaparro1,2,3,4*, J.L. Cabriada5, M.J. Casanova1,2,4, D. Ceballos6, M. Esteve4,7, H. Fernández8, M. Barreiro-de Acosta9, V. García-Sánchez10,11, D. Ginard12, F. Gomollón4,13,14, R. Llorente Poyatos15, P. Nos4,16, S. Riestra17, M. Rivero18, P. Robledo19, C. Rodríguez Gutiérrez20, B. Sicilia21, E. Torrella22, E. García Esquinas23,24,25, J.P. Gisbert1,2,3,4, on behalf of the EpidemIBD group

1Hospital Universitario de La Princesa, Gastroenterology Unit, Madrid, Spain, 2Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain, 3Universidad Autónoma de Madrid, Madrid, Spain, 4Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain, 5Hospital de Galdakao-Usansolo, Gastroenterology Unit, Vizcaya, Spain, 6Hospital Universitario de Gran Canaria Doctor Negrín, Gastroenterology Unit, Las Palmas de Gran Canaria, Spain, 7Consorci Sanitari Terrassa, Gastroenterology Unit, Tarrasa, Spain, 8Hospital San Pedro, Gastroenterology Unit, Logroño, Spain, 9Hospital Clínico Universitario de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain, 10Hospital Universitario Reina Sofía, Gastroenterology Unit, Córdoba, Spain, 11IMIBIC, Córdoba, Spain, 12Hospital Universitario Son Espases, Gastroenterology Unit, Palma de Mallorca, Spain, 13Hospital Clínico Universitario Lozano Blesa, Gastroenterology Unit, Zaragoza, Spain, 14ISS Aragón, Zaragoza, Spain, 15Hospital General Universitario de Ciudad Real, Gastroenterology Unit, Ciudad Real, Spain, 16Hospital Universitario y Politécnico de La Fe, Gastroenterology Unit, Valencia, Spain, 17Hospital Universitario Central de Asturias, Gastroenterology Unit, Oviedo, Spain, 18Hospital Universitario de Marqués de Valdecilla, Gastroenterology Unit, Santander, Spain, 19Hospital San Pedro de Alcántara, Gastroenterology Unit, Cáceres, Spain, 20Complejo Hospitalario de Navarra, Gastroenterology Unit, Pamplona, Spain, 21Hospital Universitario de Burgos, Gastroenterology Unit, Burgos, Spain, 22Hospital General Universitario Morales Meseguer, Gastroenterology Unit, Murcia, Spain, 23Universidad Autónoma de Madrid, Preventive Medicine and Public Health, Madrid, Spain, 24IdiPAZ, Madrid, Spain, 25Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain

P258: 3D printed models in fistulising perianal Crohn's as a clinical tool boost education with patients and traineesECCO '18 Vienna
Year: 2018
Authors:

K. Sahnan1*, S.O. Adegbola1, P.J. Tozer1, A. Gupta2, J. Warusavitarne1, O.D. Faiz1, A.L. Hart3, R.K. Phillips1, P.F. Lung2

1St Mark's Hospital, Colorectal Surgery, London, UK, 2St Mark's Hospital, Gastrointestinal Imaging, London, UK, 3St Mark's Hospital, IBD/Physiology, London, UK

P259: Measures of predicting inflammatory and fibrotic strictures in Crohn’s disease patients using magnetic resonanceECCO '18 Vienna
Year: 2018
Authors:

R. Stack1*, C. O'Brien2, T. Nuzum3, L. Kumar3, P. Maheshwari3, N. Breslin4,5, B. Ryan4,5, A. O'Connor3, I. Murphy6, D. Mc Namara4,5

1Tallaght Hospital, Gastroenterology, Dublin 24, Ireland, 2Talllaght Hospital, Dublin, Ireland, 3Talllaght Hospital, Gastroenterology, Dublin, Ireland, 4Adelaide and Meath Hospital, Dublin, Incorporating The National Children's Hospital, Department of Gastroenterology, Dublin, Ireland, 5Trinity College Dublin, Dublin, Ireland, 6Adelaide and Meath Hospital, Dublin, Incorporating The National Children's Hospital, Department of Radiology, Dublin, Ireland

P260: Point of Care Ultrasound (POCUS) when performed by gastroenterologists with 200 supervised scans is accurate and clinically useful for patients with Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

I. Wang1, M. Kamm1,2, D. Wong1,2, S. Bell1,2, W. Connell1, A. Thompson1,2, K. Novak3, E. Wright1*

1St Vincent's Hospital, Department of Gastroenterology, Melbourne, Australia, 2The University of Melbourne, Parkville, Australia, 3University of Calgary, Department of Gastroenterology, Calgary, Canada

P261: Asking about bowel control problems in IBD: Results of face-to-face screening vs. self-reportingECCO '18 Vienna
Year: 2018
Authors:

C. Norton1*, A. Hart2, J. Duncan3, A. Emmanuel4, C. Knowles5, S. Kerry6, D. Lanz6, V. Berdunov6, V. Madurasinghe6, H. Terry7, A. Verjee8, L. Dibley9,10

1King's College London, Florence Nightingale School of Nursing and Midwifery, London, UK, 2St Mark's Hospital, Harrow, London, UK, 3Guy's and St Thomas' NHS Foundation Trust, Department of Gastroenterology, London, UK, 4University College Hospital, Gi Division, London, UK, 5Queen Mary University London, London, UK, 6Queen Mary University London, Pragmatic Clinical Trials Unit, London, UK, 7Crohn's and Colitis UK, Department of Policy, Public Affairs, and Research, St Albans, UK, 8Patient representative, London, UK, 9University of Greenwich, Faculty of Education and Health, London, UK, 10Bart's Health NHS Trust, Academic Research Centre, London, UK

P262: New faecal calprotectin cut-off points for remission and active disease defined by UCEIS and Nancy indices in ulcerative colitis (UC)ECCO '18 Vienna
Year: 2018
Authors:

A. Walsh1*, A. Kormilitzin2, C. Hinds3, V. Sexton4, S. Bond3, J. Wilson1, O. Brain1, S. Keshav1, H. Uhlig1, J. Geddes4, G. Goodwin4, M. Peters5, G. Collins6, S. Travis1

1John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, UK, 2Mathematical Institute, Oxford, UK, 3Big Data Institute, Oxford, UK, 4University of Oxford, Psychiatry Department, Oxford, UK, 5University of Oxford, Nuffield Department of Population Health, Oxford, UK, 6University of Oxford, Centre for Statistics in Medicine, Oxford, UK

P263: Evaluation of fatigue in inflammatory bowel disease: a useful tool in daily practiceECCO '18 Vienna
Year: 2018
Authors:

S. Saraiva*, J. Cortez-Pinto, R. Barosa, J. Castela, I. Rosa, J. Pereira da Silva, A. Dias Pereira

Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisboa, Portugal

P264: Investigation of inconsistent score patients by using Lewis Score and CECDAI in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

T. Omori*, S. Hosoya, K. Yasuhiro, H. Kambayashi, S. Murasugi, A. Ito, M. Yonezawa, S. Nakamura, K. Tokushige

Tokyo Women's Medical University, Institute of Gastroenterology, Tokyo, Japan

P265: Platelet activation by activated von Willebrand factor is a marker of intestinal wound healing in patients with Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

T. Manon-Jensen1*, L. Langholm1, S. Sun1, J.H. Mortensen1, Y. He1, A. Krag2, M.D. Jensen3, A.-C. Bay-Jensen1, J. Kjeldsen2, M.A. Karsdal1

1Nordic Bioscience, Biomarker and Research, Herlev, Denmark, 2Odense University Hospital, Kerteminde, Denmark, 3Lillebaelt Hospital Vejle, Internal Medicine, Section of Gastroenterology, Vejle, Denmark